Suppr超能文献

2010 年膝关节软骨缺损的治疗方法。

Treatment of knee cartilage defect in 2010.

机构信息

Service de chirurgie orthopédique, HIA Bégin, 69, avenue de Paris, 94160 Saint-Mandé, France.

出版信息

Orthop Traumatol Surg Res. 2011 Dec;97(8 Suppl):S140-53. doi: 10.1016/j.otsr.2011.09.007. Epub 2011 Oct 28.

Abstract

Treatment of knee cartilage defect, a true challenge, should not only reconstruct hyaline cartilage on a long-term basis, but also be able to prevent osteoarthritis. Osteochondral knee lesions occur in either traumatic lesions or in osteochondritis dissecans (OCD). These lesions can involve all the articular surfaces of the knee in its three compartments. In principle, this review article covers symptomatic ICRS grade C or D lesions, depth III and IV, excluding management of superficial lesions, asymptomatic lesions that are often discovered unexpectedly, and kissing lesions, which arise prior to or during osteoarthritis. For clarity sake, the international classifications used are reviewed, for both functional assessment (ICRS and functional IKDC for osteochondral fractures, Hughston for osteochondritis) and morphological lesion evaluations (the ICRS macroscopic evaluation for fractures, the Bedouelle or SOFCOT for osteochondritis, and MOCART for MRI). The therapeutic armamentarium to treat these lesions is vast, but accessibility varies greatly depending on the country and the legislation in effect. Many comparative studies have been conducted, but they are rarely of high scientific quality; the center effect is nearly constant because patients are often referred to certain centers for an expert opinion. The indications defined herein use algorithms that take into account the size of the cartilage defect and the patient's functional needs for cases of fracture and the vitality, stability, and size of the fragment for cases of osteochondritis dissecans. Fractures measuring less than 2 cm(2) are treated with either microfracturing or mosaic osteochondral grafting, between 2 and 4 cm(2) with microfractures covered with a membrane or a culture of second- or third-generation chondrocytes, and beyond this size, giant lesions are subject to an exceptional allografting procedure, harvesting from the posterior condyle, or chondrocyte culture on a 3D matrix to restore volume. Cases of stable osteochondritis dissecans with closed articular cartilage can be simply monitored or treated with perforation in cases of questionable vitality. Cases of open joint cartilage are treated with a PLUS fixation if their vitality is preserved; if not, they are treated comparably to osteochondral fractures, with the type of filling depending on the defect size.

摘要

膝关节软骨缺损的治疗是一个真正的挑战,不仅要长期重建透明软骨,还要能够预防骨关节炎。膝关节的软骨-骨损伤发生在创伤性病变或剥脱性骨软骨炎(OCD)中。这些病变可累及膝关节三个间室的所有关节面。原则上,本文综述了有症状的 ICRS 分级 C 或 D 病变,深度 III 和 IV 级,不包括对浅表病变、经常意外发现的无症状病变以及在骨关节炎之前或期间发生的吻合并发症的处理。为了清晰起见,本文回顾了国际上用于功能评估(ICRS 和功能 IKDC 用于软骨骨折,Hughston 用于软骨炎)和形态学病变评估(ICRS 宏观评估用于骨折,Bedouelle 或 SOFCOT 用于软骨炎,MOCART 用于 MRI)的分类。治疗这些病变的方法很多,但由于国家和现行法规的不同,可获得性差异很大。已经进行了许多比较研究,但它们很少具有高科学质量;中心效应几乎是恒定的,因为患者通常会被转诊到某些中心以获得专家意见。本文定义的适应证使用的算法考虑了软骨缺损的大小以及骨折病例中患者的功能需求,以及剥脱性骨软骨炎病例中碎片的活力、稳定性和大小。小于 2cm2 的骨折采用微骨折或马赛克软骨移植治疗,2-4cm2 的骨折采用微骨折覆盖膜或第二代或第三代软骨细胞培养,超过这个大小的巨大病变需要进行异体移植,取自后髁或在 3D 基质上进行软骨细胞培养以恢复体积。对于稳定的、有闭合关节软骨的剥脱性骨软骨炎病例,可以简单地进行监测,或在活力可疑的情况下进行穿孔治疗。对于有开放性关节软骨的病例,如果其活力得到保留,则采用 PLUS 固定进行治疗;如果没有,则与软骨骨折治疗类似,根据缺损大小选择填充类型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验